CClinicalTrials.gg
Status unknownNCT03118427ZF-PMDCUpdated Apr 18, 2017

Zero-fluoroscopic Navigation Versus Conventional Fluoroscopic Navigation for Double-chamber Pacemaker Implantation

An interventional study of zero-fluoroscopy 3D navigation and conventional x-ray navigation in Sick Sinus Syndrome, Complete Atrioventricular Block and High Degree Second Degree Atrioventricular Block (Disorder), sponsored by Tongji Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2017-04-18.

Sponsored by Tongji Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

This study is intended to compare the feasibility, safety and efficacy of Ensite-NavX zero-fluoroscopic navigation system to conventional fluoroscopic X-ray approach as to performing double-chamber pacemaker implantation.

Read the detailed description

Permanent pacemaker is a well-established treatment to treat patients with a wide range of heart rhythm disturbances.

Fluoroscopy is the imaging modality routinely used for cardiac device implantation and electrophysiological procedures.Due to the rising concern regarding the harmful effects of radiation exposure to both the patients and operation staffs, novel 3D mapping systems have been developed and implemented in electrophysiological procedure for the navigation of catheters inside the heart chambers.

Ensite NavX system can be used for cardiac imaging as a reliable and safe zero-fluoroscopy approach for implantation of single- or dual-chamber permanent pacemaker in patients. Our method offered a choice for some special population of patient in whom radiation exposure need to be avoided or in the extreme circumstances when the X-ray machine is out-of-order.

02

Conditions studied

  • Sick Sinus Syndrome
  • Complete Atrioventricular Block
  • High Degree Second Degree Atrioventricular Block (Disorder)
  • Bradycardia

Keywords

  • Fluoroscopy
  • Pacemaker
  • Three dimensional
  • Radiation
  • Imaging
03

In context

Bradycardia

306 studies on the registry are indexed under Bradycardia; 69 are open to participants now.

This study's planned enrollment of 100 is close to the median of 99 across 174 interventional studies indexed under Bradycardia.

Browse Bradycardia studies →

Lead sponsor

Tongji Hospital is the lead sponsor of 373 studies on the registry; 204 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Sick Sinus Syndrome
  • complete Atrioventricular Block
  • high degree second Degree Atrioventricular Block
  • Bradycardia

Exclusion criteria

Exclusion Criteria:

  • pacemaker replacement
  • severe structural cardiac malformations
  • severe cardiac enlargement
  • venous malformations
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Zero-fluoroscopy implantation

    Pacemaker implantation performed for all patients in this group with zero-fluoroscopy 3D navigation.

    Procedure: zero-fluoroscopy 3D navigation

  • Active comparator
    Conventional fluoroscopy implantation

    Pacemaker implantation performed for all patients with conventional x-ray navigation.

    Procedure: conventional x-ray navigation

Interventions

  • Procedurezero-fluoroscopy 3D navigation

    Pacemaker implantation will be performed without fluoroscopy using 3D navigation systems.

    Also known as: non-fluoroscopy 3D navigation

  • Procedureconventional x-ray navigation

    Pacemaker implantation will be performed with fluoroscopy using conventional X-ray navigation.

    Also known as: fluoroscopy navigation

06

What researchers measure

Primary outcomes

  1. Success rate

    Time frame: 3 months

Secondary outcomes

  1. Total procedure time

    Time frame: during procedure

  2. Fluoroscopy time

    Time frame: during procedure

  3. Complications

    Time frame: 1 year

07

Study locations

1 of 1 sites recruiting
  • Tongji Hospital
    Wuhan, Hubei 430030, China
    Recruiting
08

References and documents

Publications

  • Miller DL, Balter S, Schueler BA, Wagner LK, Strauss KJ, Vano E. Clinical radiation management for fluoroscopically guided interventional procedures. Radiology. 2010 Nov;257(2):321-32. doi: 10.1148/radiol.10091269. PubMed 20959547 ↗
  • Ventura R, Rostock T, Klemm HU, Lutomsky B, Demir C, Weiss C, Meinertz T, Willems S. Catheter ablation of common-type atrial flutter guided by three-dimensional right atrial geometry reconstruction and catheter tracking using cutaneous patches: a randomized prospective study. J Cardiovasc Electrophysiol. 2004 Oct;15(10):1157-61. doi: 10.1046/j.1540-8167.2004.04064.x. PubMed 15485440 ↗
  • Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results. Circulation. 1997 Mar 18;95(6):1611-22. doi: 10.1161/01.cir.95.6.1611. PubMed 9118532 ↗
  • Lemery R. Interventional electrophysiology at the crossroads: cardiac mapping, ablation and pacing without fluoroscopy. J Cardiovasc Electrophysiol. 2012 Oct;23(10):1087-91. doi: 10.1111/j.1540-8167.2012.02373.x. Epub 2012 Aug 6. No abstract available. PubMed 22882722 ↗
  • Richter S, Doring M, Gaspar T, John S, Rolf S, Sommer P, Hindricks G, Piorkowski C. Cardiac resynchronization therapy device implantation using a new sensor-based navigation system: results from the first human use study. Circ Arrhythm Electrophysiol. 2013 Oct;6(5):917-23. doi: 10.1161/CIRCEP.113.000066. Epub 2013 Sep 3. PubMed 24002003 ↗
  • Wittkampf FH, Wever EF, Derksen R, Wilde AA, Ramanna H, Hauer RN, Robles de Medina EO. LocaLisa: new technique for real-time 3-dimensional localization of regular intracardiac electrodes. Circulation. 1999 Mar 16;99(10):1312-7. doi: 10.1161/01.cir.99.10.1312. PubMed 10077514 ↗
  • Schreieck J, Ndrepepa G, Zrenner B, Schneider MA, Weyerbrock S, Dong J, Schmitt C. Radiofrequency ablation of cardiac arrhythmias using a three-dimensional real-time position management and mapping system. Pacing Clin Electrophysiol. 2002 Dec;25(12):1699-707. doi: 10.1046/j.1460-9592.2002.01699.x. PubMed 12520670 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03118427
Lead sponsor
Tongji Hospital
Collaborators
Fu Wai Hospital, Beijing, China, Xinyang Central Hospital, First Affiliated Hospital of Guangxi Medical University, Guangdong Provincial People's Hospital, Wuhan Asia Heart Hospital, Shenzhen Sun Yat-sen Cardiovascular Hospital, Ningbo No. 1 Hospital
Responsible party
Yan Wang (Professor, Tongji Hospital) — Principal investigator
First posted
Apr 18, 2017
Start date
Jan 2013
Primary completion
Dec 2018 (estimated)
Completion
Dec 2020 (estimated)
Last update
Apr 18, 2017

Study contacts

Yan Wang, PhD
Contact
newswangyan@tjh.tjmu.edu.cn
86-027-83663280
Guangzhi Chen, PhD
Contact
chengz2003@163.com
86-027-83662842
Yan Wang, PhD
principal investigator · Tongji Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion